Literature DB >> 33505549

Predictors of recurrent angina in patients with no need for secondary revascularization.

Tian Xu1,2, Ya Li1,2, Li-Ding Zhao1,2, Guo-Sheng Fu1,2, Wen-Bin Zhang1,2.   

Abstract

BACKGROUND: Approximately 20% to 30% of patients with coronary artery disease (CAD) develop recurrent angina pectoris following successful and complete coronary revascularization utilizing percutaneous coronary intervention (PCI). We aim to investigate predictors of recurrent angina pectoris in patients who have undergone successful coronary revascularization using PCI, but on repeat coronary angiography have no need for secondary revascularization.
METHODS: The study comprised 3,837 patients with CAD, who were enrolled from January 2007 to June 2019. They had undergone successful PCI; some of them redeveloped angina pectoris within one year after the procedure, but on repeat coronary angiography had no need for revascularization. Thrombolysis in myocardial infarction (TIMI) frame count was used to evaluate the velocity of coronary blood in the follow-up angiogram. Multivariate logistic regression was used to investigate risk factors for recurrent angina pectoris. Similarly, predictors of recurrent angina according to the TIMI frame count were assessed using multivariate linear regression.
RESULTS: In this retrospective study, 53.5% of patients experienced recurrent angina pectoris. By multivariate logistic regression, the following characteristics were statistically identified as risk factors for recurrent angina pectoris: female sex, older age, current smoking, low-density lipoprotein cholesterol (LDL-C) ≥1.8 mmol/L, and an elevated TIMI frame count (P for all <0.05). Similarly, using multivariate linear regression, the statistical risk factors for TIMI frame count included: female sex, older age, diabetes, body mass index (BMI), post-procedural treatment without the inclusion of dual antiplatelet therapy.
CONCLUSIONS: Patient characteristics of female sex, older age, diabetes, and elevated BMI are associated with an increased TIMI frame count, coronary microcirculation dysfunction, and recurrent angina pectoris after initially successful PCI. In addition, current smoking and LDL-C ≥1.8 mmol/L are risk factors for recurrent angina pectoris. In contrast, the treatment with dual antiplatelet therapy is negatively correlated with a higher TIMI frame count and the risk of recurrent angina pectoris. Copyright: © World Journal of Emergency Medicine.

Entities:  

Keywords:  Predictors; Recurrent angina; Thrombolysis in myocardial infarction frame count

Year:  2021        PMID: 33505549      PMCID: PMC7790702          DOI: 10.5847/wjem.j.1920-8642.2021.01.007

Source DB:  PubMed          Journal:  World J Emerg Med        ISSN: 1920-8642


  31 in total

1.  Nicorandil prevents microvascular dysfunction resulting from PCI in patients with stable angina pectoris: a randomised study.

Authors:  Atsushi Hirohata; Keizo Yamamoto; Eiki Hirose; Yuhei Kobayashi; Hiroya Takafuji; Fumihiko Sano; Kensuke Matsumoto; Minako Ohara; Ryo Yoshioka; Hiroyuki Takinami; Tohru Ohe
Journal:  EuroIntervention       Date:  2014-01-22       Impact factor: 6.534

2.  Cost-Effectiveness of Different Durations of Dual-Antiplatelet Use After Percutaneous Coronary Intervention.

Authors:  Yaron Arbel; Maria C Bennell; Shaun G Goodman; Harindra C Wijeysundera
Journal:  Can J Cardiol       Date:  2017-10-06       Impact factor: 5.223

Review 3.  Thromboinflammatory Functions of Platelets in Ischemia-Reperfusion Injury and Its Dysregulation in Diabetes.

Authors:  Sophie Maiocchi; Imala Alwis; Mike Chia Lun Wu; Yuping Yuan; Shaun P Jackson
Journal:  Semin Thromb Hemost       Date:  2018-01-02       Impact factor: 4.180

4.  Endothelial dysfunction as predictor of angina recurrence after successful percutaneous coronary intervention using second generation drug eluting stents.

Authors:  Rocco A Montone; Giampaolo Niccoli; Federico Vergni; Vincenzo Vetrugno; Michele Russo; Fabio Mangiacapra; Francesco Fracassi; Italo Porto; Antonio M Leone; Francesco Burzotta; Domenico D'Amario; Cristina Aurigemma; Carlo Trani; Gaetano A Lanza; Filippo Crea
Journal:  Eur J Prev Cardiol       Date:  2018-05-22       Impact factor: 7.804

5.  Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial.

Authors:  Jessica L Mega; David A Morrow; Marc S Sabatine; Xue-Qiao Zhao; Steven M Snapinn; Peter M DiBattiste; C Michael Gibson; Elliott M Antman; Eugene Braunwald; Pierre Théroux
Journal:  Am Heart J       Date:  2005-05       Impact factor: 4.749

6.  Thermodilutional Confirmation of Coronary Microvascular Dysfunction in Patients With Recurrent Angina After Successful Percutaneous Coronary Intervention.

Authors:  Yi Li; Daya Yang; Lihe Lu; Dexi Wu; Jianping Yao; Xun Hu; Ming Long; Chufan Luo; Zhimin Du
Journal:  Can J Cardiol       Date:  2015-03-11       Impact factor: 5.223

7.  Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease.

Authors:  Stephen G Ellis; Dean J Kereiakes; D Christopher Metzger; Ronald P Caputo; David G Rizik; Paul S Teirstein; Marc R Litt; Annapoorna Kini; Ameer Kabour; Steven O Marx; Jeffrey J Popma; Robert McGreevy; Zhen Zhang; Charles Simonton; Gregg W Stone
Journal:  N Engl J Med       Date:  2015-10-12       Impact factor: 91.245

8.  Temporal trends in patient-reported angina at 1 year after percutaneous coronary revascularization in the stent era: a report from the National Heart, Lung, and Blood Institute-sponsored 1997-2006 dynamic registry.

Authors:  Lakshmi Venkitachalam; Kevin E Kip; Suresh R Mulukutla; Faith Selzer; Warren Laskey; James Slater; Howard A Cohen; Robert L Wilensky; David O Williams; Oscar C Marroquin; Kim Sutton-Tyrrell; Clareann H Bunker; Sheryl F Kelsey
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-10-13

9.  Coronary Microvascular Dysfunction in Rheumatoid Arthritis Compared to Diabetes Mellitus and Association With All-Cause Mortality.

Authors:  Katherine P Liao; Jie Huang; Zeling He; Gabrielle Cremone; Ethan Lam; Jon M Hainer; Victoria Morgan; Courtney Bibbo; Marcelo Di Carli
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-02       Impact factor: 4.794

Review 10.  Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014.

Authors:  Robert A Byrne; Michael Joner; Adnan Kastrati
Journal:  Eur Heart J       Date:  2015-09-28       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.